Publication | Closed Access
Long-lasting treatment effect of rituximab in MuSK myasthenia
337
Citations
6
References
2012
Year
This study provides Class IV evidence that IV rituximab improves the clinical and immunologic status of patients with MuSK+MG.
| Year | Citations | |
|---|---|---|
Page 1
Page 1